Lobbying Relationship

Client

Roche Diagnostics Corporation

More records

Lobbying firm

Brown Rudnick LLP

More records

  • H.R. 3271 - Protecting Access to Diabetic Testing Supplies Act of 2017;S. 1914 - Protecting Access to Diabetes Supplies Act of 2017;Yet to be introduced House proposal for a regulatory framework for in-vitro clinical tests.
  • H.R. 3271 - Protecting Access to Diabetic Testing Supplies Act of 2017;S. 1914 - Protecting Access to Diabetes Supplies Act of 2017;Yet to be introduced House and Senate proposal for a regulatory framework for in-vitro clinical tests.

Duration: to

General Issues: Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code

Spending: about $990,000 (But it's complicated. Here's why.)

Agencies lobbied since 2012: U.S. Senate, House of Representatives

Bills mentioned

H.R.3271: Protecting Access to Diabetes Supplies Act of 2017

Sponsor: Diana DeGette (D-Colo.)

S.1914: Protecting Access to Diabetes Supplies Act of 2017

Sponsor: Mark Warner (D-Va.)

H.R.771: Protecting Access to Diabetes Supplies Act of 2015

Sponsor: Diana DeGette (D-Colo.)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

H.R.1726: Access to Quality Diabetes Education Act of 2015

Sponsor: Edward Whitfield (R-Ky.)

S.1101: MEDTECH Act

Sponsor: Michael Bennet (D-Colo.)

S.232: Medical Device Access and Innovation Protection Act

Sponsor: Orrin G. Hatch (R-Utah)

H.R.523: Protect Medical Innovation Act of 2013

Sponsor: Erik Paulsen (R-Minn.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Lisa Layman CBO, PA(92-96); LA, Sen Chafee(97-99); LA, Sen Bryan(00); SPA, Sen Graham(01-04); SPA, Sen Stabenow(05-07) SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) SPA, Sen. Stabenow (05-07)
Henry Menn III CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995) Sp Asst Leg Aff, FDA Off of Commiss(93-95); CoS, Sen Bob Graham(01-04); Min SD & Counsel, Cmte on Vet Affairs (04) CoS, Sen. Bob Graham (01 - 04)
ROBERT FOREMAN The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005)
Christopher Bowlin Hlth & Dom Policy Adv, Sen McCain, 09-Aug 13; Dep Asst Secr for Legisl, HHS, 08-09 Dep Asst Secr for Congr & Intgv Affairs, Dept. Labor 01-02 Prof Staff, House Cmte on Ed & Workforce 99-01
Henry W Menn III Sp Asst Leg Aff, FDA Off of Commiss(93-95); CoS, Sen Bob Graham(01-04); Min SD & Counsel, Cmte on Vet Affairs (04)

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Amendment
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page